G protein-coupled receptors as targets for anti-diabetic therapeutics

Nature Reviews. Drug Discovery
Da Young Oh, Jerrold M Olefsky

Abstract

The prevalence of obesity and type 2 diabetes (T2D) is increasing worldwide, and these two metabolic disorders are closely linked. Lifestyle modification, including weight loss and exercise, are effective treatments for T2D, but, unfortunately, most patients are unsuccessful at maintaining durable weight reduction and recidivism is all too common. Therefore, safe and efficacious drugs are required for the successful treatment of T2D in a large proportion of patients. Targeting G protein-coupled receptors (GPCRs) in metabolic tissues - such as adipose tissue, liver, muscle, pancreatic islets, immune cells and the central nervous system - has emerged as a key target for current and future anti-diabetic compounds. This Opinion focuses on the potential of GPCRs as targets for the discovery of new drugs to successfully treat T2D.

References

Aug 1, 1973·The Journal of Clinical Investigation·S R CrespinD Steinberg
Jun 15, 1996·The Journal of Clinical Investigation·D T SteinJ D McGarry
Sep 3, 1999·American Journal of Respiratory and Critical Care Medicine·A T HillR A Stockley
Oct 19, 2002·Circulation Research·Randy A Hall, Robert J Lefkowitz
Dec 24, 2002·The Journal of Biological Chemistry·Celia P BriscoeAlison I Muir
Jan 10, 2003·The Journal of Clinical Endocrinology and Metabolism·T VilsbøllJ J Holst
Feb 26, 2003·Circulation·Christophe CombadièreZiad Mallat
Jul 2, 2003·Thorax·P MontuschiP J Barnes
Sep 19, 2003·Diabetologia·G C Yaney, B E Corkey
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Annemieke KavelaarsCobi J Heijnen
Dec 21, 2004·Biochemical and Biophysical Research Communications·Takatoshi SogaKiyoshi Furuichi
Dec 28, 2004·Nature Medicine·Akira HirasawaGozoh Tsujimoto
Jan 19, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·B Ahrén, O Schmitz
Apr 13, 2005·Lancet·Michael StumvollTimon W van Haeften
May 26, 2005·American Journal of Physiology. Endocrinology and Metabolism·Ken FujiwaraToshihiko Yada
Aug 6, 2005·Biochemical and Biophysical Research Communications·Hagit ShapiroMichael D Walker
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
Mar 29, 2006·The Journal of Experimental Medicine·Mei ChenDavid M Lee
May 30, 2006·Nature Neuroscience·Astrid E CardonaRichard M Ransohoff
Jul 11, 2006·The Journal of Clinical Investigation·Steven E ShoelsonAllison B Goldfine
Jul 11, 2006·The Journal of Clinical Investigation·Marc Prentki, Christopher J Nolan
Sep 14, 2006·Pharmacological Reviews·Giancarlo Folco, Robert C Murphy
Dec 15, 2006·Nature·Steven E KahnKristina M Utzschneider
Dec 26, 2006·Biochimica Et Biophysica Acta·Brian K Kobilka

❮ Previous
Next ❯

Citations

Apr 20, 2017·Scientific Reports·Stefan AmistenShanta J Persaud
Nov 10, 2018·Nature Reviews. Drug Discovery·Ichio ShimadaKurt Wüthrich
Dec 6, 2018·Current Drug Targets·Jianting GongHan Wang
Jul 6, 2019·Food & Function·Li-Chun ChenShi-Yu Zhang
Sep 6, 2019·Physiological Reviews·Ikuo KimuraMiki Igarashi
Aug 31, 2018·Current Drug Discovery Technologies·Krishna A Gajjar, Anuradha K Gajjar
Feb 20, 2020·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Medha PriyadarshiniBrian T Layden
Aug 29, 2020·Genes·Chase H Melick, Jenna L Jewell
Oct 28, 2017·Nature Reviews. Drug Discovery·Alexander S HauserDavid E Gloriam
Apr 14, 2018·Indian Journal of Clinical Biochemistry : IJCB·Gaurav ChikaraSurjit Singh
Mar 14, 2019·Frontiers in Endocrinology·Sine Paasch SchiellerupMette Marie Rosenkilde
Sep 13, 2019·Current Topics in Medicinal Chemistry·Manveen K Gupta, Neelakantan T Vasudevan
Oct 17, 2017·Annual Review of Physiology·S Steensels, I Depoortere
May 16, 2019·EBioMedicine·Simin ZhaoZigang Dong
Jun 3, 2021·International Journal of Molecular Sciences·Esraa HajiSameer Mohammad
May 28, 2021·Endocrinology·Gage M Stuttgen, Daisy Sahoo
Apr 28, 2020·Journal of Chemical Information and Modeling·Dan TengGuixia Liu
Feb 20, 2018·Journal of Medicinal Chemistry·Shaoyong Lu, Jian Zhang
May 10, 2018·Trends in Endocrinology and Metabolism : TEM·Amin ArdestaniKathrin Maedler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Current Opinion in Investigational Drugs
Christina BjenningDominic Behan
Pharmaceutical Patent Analyst
Thaïs RouquetBruno Bariohay
Trends in Pharmacological Sciences
Kaspar HollensteinRaymond C Stevens
© 2021 Meta ULC. All rights reserved